Attention-deficit/hyperactivity disorder: A selective overview;Trouble déficitaire de l'attention avec hyperactivité chez l'adulte

Annales Medico-Psychologiques

Volumn 165, Issue 5, 2007, Pages 378-385

  Grosse, E M ^a   Da Fonseca, D ^b   Fakra, E ^b   Poinso, F ^b   Samuelian, J C ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Adult; Attention Deficit; Hyperactivity

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ATOMOXETINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; COMORBIDITY; CONDUCT DISORDER; DISSOCIATIVE DISORDER; GENERAL PRACTITIONER; HEREDITY; HUMAN; HYPERACTIVITY; IMPULSIVENESS; NEUROBIOLOGY; NEUROPSYCHOLOGY; PREVALENCE; PROGNOSIS; PSYCHOEDUCATION; PSYCHOLOGICAL ASPECT; SEX RATIO; SOCIAL WORKER;

EID: 34249802915     PISSN: 00034487     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amp.2007.04.001     Document Type: Article

References (62)

1. Amen D. Brain SPECT imaging in ADHD. J. Am. Acad. Child Adolesc. Psychiatry 5 (1993) 1079-1080 (letter)
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (third edition). Washington, DC (1980)
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (third edition, revised). Washington, DC (1987)
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (fourth edition). Washington, DC (1994)
5. Arcia E., and Gualieri C.T. Neurobehavioral performance of adults with closed-head injury, adults with attention deficit, and controls. Brain Inj. 8 (1994) 395-404
6. Bange F., and Mouren M. Comprendre et Soigner l'hyperactivité chez l'adulte. Collections Psychothérapies (2005), Dunod, Paris
7. Barkley R.A. ADHD and the nature of self-control (1997), Guilford, New-York
8. Barkley R.A., and Grodzinsky G. Are tests of frontal lobe functions useful in the diagnosis of attention deficit disorders?. Clin. Neuropsychol. 8 (1994) 121-139
9. Barkley R.A., Murphy K.R., and Kwasnik D. Motor Vehicle Competencies and Risks in Teens and Young Adults with Attention Deficit Hyperactivity Disorder. Pediatrics 98 (1996) 1089-1095
10. Berquin P.C., Giedd J.N., Jacobsen L.K., Hamburger S.D., Krain A.L., Rapoport J.L., et al. Cerebellum in attention-deficit hyperactivity disorder: A morphometric MRI study. Neurology 50 (1998) 1087-1093
11. Biederman J., Faraone S., Spencer T., Wilens T., Normal D., Lapey K.A., et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with Attention Deficit Hyperactivity Disorder. Am. J. Psychiatry 150 (1993) 1792-1798
12. Biedermann J., Faraone S.V., Mick E., Spencer T., Wilens T., Keily K., et al. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: A pilot study. Am. J. Psychiatry 152 (1995) 431-435
13. Bouvard M., Le Heuzey M.F., Mouren-Simeoni M.C., Abbou H., Bange F., Martin C., et al. L'hyperactivité de l'enfance à l'âge d'adulte (2002), Doin Collection conduits, Paris
14. Casey B.J., Castellanos F.X., Giedd J.N., Marsh W.L., Hamburger S.D., Schubert A.B., et al. Implication of right frontostriatal circuity in response inhibition and attention- deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36 (1997) 374-383
15. Castellanos F.X. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin. Pediatr. 36 (1997) 381-393
16. Castellanos F.X. Cerebellum in attention-deficit hyperactivity disorder: A morphometric MRI study. Neurology 50 (1998) 1087-1093
17. Classification internationale des maladies et des problèmes de santé connexes. CIM 10 (1993) (dixième édition)
18. Comings D.E. Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann. N. Y. Acad. Sci. 931 (2001) 50-83
19. Cook E.H., Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieffer J.E., et al. Association of attention deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56 (1995) 993-998
20. Cox D.J., Merkel R.L., Kovachev B., and Seward R. Effect of Stimulant Medication on Driving Performance of Young Adults with Attention-Deficit/Hyperactivity Disorder. J. Nerv. Ment. Dis. 188 (2000) 230-234
21. Dorrego M.F., Canevaro L., Kuzis G., Sabe L., and Starkstein S.E. A randomized, double-blind, crossover study of méthylphénidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. J. Neuropsychiatry Clin. Neurosci. 14 (2002) 289-295
22. Dougherty D.D., Bonab A.A., Spencer T.J., Rauch S.L., Madras B.K., and Fischmann A.J. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354 (1999) 2132-2133
23. Dresel S.H.J., Kung M.P., Ploessl K., Meegalla S.K., and Kung H.F. Pharmacological effects of dopaminergic drugs on in vivo binding of (99m Tc)TRODAT-1 to the central dopamine transporters in rats. Eur. J. Nucl. Med. 25 (1998) 31-39
24. Ernst M., Zametkin A.J., Matochik J.A., Jons P.H., and Cohen R.M. DOPA decarboxylase activity in attention deficit hyperactivity disorder in adults. J. Neurosci. 18 (1998) 5901-5907
25. Faraone S.V., Biederman J., Weiffenbach B., Keith T., Chu M.P., Weaver A., et al. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am. J. Psychiatry 156 (1999) 768-770
26. Faraone S.V., and Biederman J. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis. J. Atten. Disord. 6 (2002) 69-75
27. Hettema J.M., Neale M.C., and Kendler K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 158 (2001) 1568-1578
28. Holdnack J.A., Moberg P.J., Arnold S.E., Gur R.C., and Gur R.E. Speed of processing and verbal learning deficits in adults diagnosed with attention deficit disorder. Neuropsychiatry Neuropsychol. Behav. Neurol. 8 (1995) 282-292
29. Hornig-Rohan M, Amsterdam JD, Venlafaxine vs Stimulant Therapy in Patients with Dual. Diagnoses of Attention Deficit Disorder and Depression. Programm Book for the Annual Meeting of the New Drug Clinical Evaluation Unit, Boca Raton, Florida; 1995.
30. Hynd G.W., Semrud-Clikeman M., Lorys A.R., Novey E.S., Eliopulos D., and Lyytinen H. Corpus callosum morphology in attention deficit hyperactivity disorder: Morphometric analysis of MRI. J. Learn. Disabil. 24 (1991) 141-146
31. Hynd G.W., Semrud-Clikeman M., Lorys A.R., Novey E.S., and Eliopulos D. Brain morphology in developmental dyslexia and attention deficit hyperactivity disorder. Arch. Neurol. 47 (1990) 919-926
32. Jenkins M., Cohen R., Malloy P., Salloway S., Johnsen E.G., Penn J., et al. Neuropsychological measures which discriminate among adults with residual symptoms of Attention Deficit Disorder and other attentional complaints. Clin. Neuropsychol. 12 (1998) 74-83
33. Klee S.H., Garfinkel B.D., and Beauchesne H. Attention deficit in adults. Psychiatr. Ann. 16 (1986) 52-56
34. Kuperman S., Perry P.J., Gaffney J.R., Lund B.C., Bever-Stille K.A., Arndt S., et al. Buproprion SR vs. Methylphenidate vs Placebo for attention deficit hyperactivity disorder in adults. Ann. Clin. Psychiatry 13 (2001) 129-134
35. Lichter J.B., Barr C.L., Kennedy J.L., et al. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum. Mol. Genet. 2 (1993) 767-773
36. Linehan M. Cognitive-Behavioral Treatment of Borderline Personality Disorder (1993), Guildford Press, New York
37. Lou H.C., Henriksen L., and Bruhn P. Focal cerebral hypoperfusion in children with dysphoria and/or attention deficit hyperactivity disorder. Arch. Neurol. 41 (1984) 825-882
38. Matochik J.A., Rumsey J.M., Zametkin A.J., Hamburger S.D., and Cohen R.M. Neuropsychological correlates of familial Attention- Deficit Hyperactivity Disorder in adults. Neuropsychiatry, Neurosurgery & Neurology 9 (1996) 186-191
39. Mattes J.A. Propranolol for adults with attention temper outbursts and residual attention deficit disorder. J. Clin. Psychopharmacol. 6 (1986) 299-302
40. Michelson D., Adler L., Spencer T., Reimherr F.W., West S.A., Allen A.J., et al. Atomoxetine in adults with ADHD: Two randomized, placebo controlled studies. Biol. Psychiatry 15 53 (2003) 112-120
41. Mick E., Biederman J., Prince J., Fischer M.J., and Faraone S.V. Impact of low birth weight on attention-deficit hyperactivity disorder. J. Dev. Behav. Pediatr. 23 (2002) 16-22
42. Moser D.J., and Paulsen J.S. Buproprion SR vs Methylphenidate vs Placebo for attention deficit hyperactivity disorder. Ann. Clin. Psychiatry 13 (2001) 129-134
43. Murphy K., and Barkley R.A. Attention deficit hyperactivity disorder adults : Comorbidities and adaptive impairements. Compr. Psychiatry 37 (1996) 393-401
44. Pauls D.L., Leckman J.F., and Cohen D.J. Familial relationship between Gilles de la Tourette syndrome, attention deficit hyperactivity disorder, learning disabilities, speech disorders and stuttering. J. Am. Acad. Child Adolesc. Psychiatry 32 (1993) 1044-1050
45. Pliszka S.R. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: An overview. J. Clin. Psychiatry 59 (1998) 50-58
46. Ratey J.J., Greenberg M.S., and Lindem K.J. Combination of treatments for attention deficit hyperactivity in adults. J. Nerv. Ment. Dis. 179 (1991) 699-701
47. Reimherr F.W., Wender P.H., Ebert M.H., and Wood D.R. Cerebrospinal fluid homovanillic acid and 5-hydroxy-indoleacetic acid in adults with attention deficit disorder, residual type. Psychiatry Res. 11 (1984) 71-78
48. Spencer T., Wilens T.E., Biedermann J., et al. A double blind, crossover comparison of méthylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch. Gen. Psychiatry 52 (1995) 434-443
49. Still G.F. Some abnormal psychical conditions in children. Lancet 1 (1902) 1008-1012
50. Swanson J.M. Role of executive function in ADHD. J. Clin. Psychiatry 64 Suppl 14 (2003) 35-39
51. Turner D.C., Clark L., Dowson J., Robbins T.W., and Sahakian B.J. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol. Psychiatry 55 (2004) 1031-1040
52. Von Economo C. Encephalitis Lethargica, its sequelae and treatment. Trarans KL Newman (1930), Oxford university Press, London
53. Walker A.J., Shores E.A., Trollor J.N., Lee T., and Sachdev P.S. Neuropsychological functioning of adults with attention deficit hyperactivity disorder. J. Clin. Exp. Neuropsychol. 22 (2000) 115-124
54. Wender P.H. Minimal brain dysfunction in children (1971), Wiley, New York
55. Wender P.H., and Reimherr F.W. Buproprion treatment of attention deficit hyperactivity disorder in adults. Am. J. Psychiatry 147 (1990) 1018-1020
56. Wender P.H. Die Aufmerksamkeitsdefizit-/Hyperaktivitaetsstoerung(ADHD) im Erwachsenenalter. Psycho 26 (2000) 190-198
57. Wender P.H., Wolf L.E., and Wasserstein J. Adults with ADHD: An overview. Ann. N. Y. Acad. Sci. 931 (2001) 1-16
58. Wilens T.E., Biederman J., Mick E., et al. A systematic assessment of tricyclic antidepressants in the treatment of attention-deficit hyperactivity disorder. J. Nerv. Ment. Dis. 183 (1995) 48-50
59. Wilens T.E., Biederman J., Spencer T.J., Bostic J., Prince J., Monuteaux, et al. A pilot controlled clinical trial of ABT-18, a cholinergic agonist in the treatment of adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 156 (1999) 1931-1937
60. Woodward L.J., Fergusson D.M., and Horwood L.J. Driving Outcomes of Young People With Attentional Difficulties in Adolescence. J. Am. Acad. Child Adolesc. Psychiatry 39 (2000) 627-634
61. Zametkin A.J., Liebenauer L.L., Fitzgerald G.A., King A.C., Minkunas D.V., Herscovitch P., et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 50 (1993) 333-340
62. Zametkin A.J., Nordahl T.E., Gross M., King A.C., Semple W.E., Rumsey J., et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N. Engl. J. Med. 323 (1990) 1361-1366